SUMMAR'\'. Polarisation fluorescence was used to assess the antibody response in sheep immunised with 4-aminosalicylic acid coupled to keyhole limpet haemocyanin and to develop a polarisation fluoroimmunoassay for subsequent clinical USl'. The fluorescent label was prepared by coupling 4-aminosalicylic acid to fluorescein isothiocyanate. All immunised sheep produced antibodies and a simple assay was developed using salicylic acid as the standard. The simple fluorescence polarisation approach enabled the rapid and direct study of the immuno-reactivity of ,I large number of pure chemical analogues of salicylic acid. Each was assessed for its ability to compete with the fluorophore-labellcd analytc for antibody-binding sites, relative to salicylate, thereby enabling investigation of the stcric and chemical characteristics important in the recognition and binding of a hapten to antibodies.
For several years our department has been actively involved in developing simple polarisation fluoroimmunoassays (PFIA) for drugs of clinical importance such as gentamicin' and phenytoin, The method offers advantages of speed and simplicity and does not require a separation step. The principles of fluorescence polarisation have been described in detail by Dandliker and his colleagues.r" In brief, PFIA is based on the small fluorescence polarisation signal given by fluorophore-Iabelled haptens, due to their rapid rate of Brownian motion. The rate of such motion decreases substantially after antibody binding, with consequent increase in the polarisation signal.
During the development of a PFIA for emergency use in patients with salicylate poisoning, antisera were successfully raised in sheep immunised with 4-aminosalicylic acid coupled to the carrier protein, keyhole limpet haernocyanin (KLH). In view of the low molecular weight of salicylic acid (138 daltons), its simple but prominent chemical features (a phenyl ring, a carboxylic acid and a phenolic hydroxyl) and the availability of a large number of structurally-related compounds. it was of interest to study the structural features of the analyte involved in binding by antibodies.
The most extensive studies of this type were undertaken by Landsteiner and his colleagues Correspondence: G Gallacher, 374 in the first half of the century and arc summarised in his book The Specificity of Serological Reactions. h These were based on the inhibition of the precipitation reaction between antibodies to a hapten-protein conjugate and the same hapten coupled to a different protein.
Although. at the time, the existence of the antibody molecule was only suspected. the thoroughness of the work led to conclusions regarding the fundamental nature of the extent and specificity of the immune response to small molecules linked, as haptens. to carrier proteins. Polarisation f1uoroimmunoassay offers a much simpler and quicker technique to undertake such studies and salicylic acid provides ,10 excellent model. Antibodies to salicylate 375 added dropwise to a solution of KLH (1-7 mL; 100 mg) in water (10 mL) with stirring. the pH adjusted to 6 by addition of sodium bicarbonate (2 M) and the reaction mixture left to stir for 6() min at room temperature. Finally. the hapten-KLH bridge was stabilised by reduction with sodium borohydride (100 mg), added slowly over 30 min, the reaction mixture dialysed against running tap water for 3 days at room temperature and then Iyophilised to obtain 100 mg of immunogen ( Fig. I) . below the mean for the 'zero standard'. Those that cross-reacted slightly were reassayed at initial concentrations of 1000. 2(KKl. ](KKl and 4(KKl mg/L, whilst the compounds which crossreacted significantly were assayed at the same concentrations as salicylic acid. The crossreactivities were calculated relative to salicylic acid according to the formula:
Materials and methods

REAGENTS
In the event of non-parallelism between the standard curve for salicylic acid and for the analogue. cross-reactivity was calculated at several points and the maximum value recorded.
It was not possible to determine the crossreactivity of the labelled analyte relative to salicylic acid by this means and an alternative approach was adopted. Antiserum dilution curves were prepared with the label at a final concentration of 10 nmol/L and of IIKl nmol/L and. in a third. using 10 nmol/L fluoresceinlabelled 4-aminosalicylic acid and l)O nmol/L unlabelled salicylic acid.
376 Bennett. Gallacher and Landon off. eluted in methanol, centrifuged (2500 rpm; 15 min) and the supernatant aspirated and stored at -20°C ( Fig. I) .
PRODUCTION AND ASSESSMENT OF ANTISERA Six mature ewes were immunised. On the first occasion each ewe received 4 mL of a water-inoil emulsion of an aqueous solution of I mL of immunogen (2 mg) with 3 mL of Freund's complete adjuvant, injected subcutaneously into all four limbs and both sides of the neck. This was repeated at 4 week intervals except that Freund's incomplete adjuvant was used. The animals were bled from the external jugular vein 2 weeks after each reimmunisation and the blood allowed to clot overnight. centrifuged and the serum separated and stored at -20°C.
The antisera were assessed by performing antiserum dilution curves and determining fluorescence polarisation. Serum from a nonimmunised normal ewe was used as control. A series of 12 doubling dilutions (from an initial IO-fold dilution) were prepared with 1 mL of each being incubated with the fluorophorelabelled analyte (0·5 mL; 30 nmol/L) for 30 min and the polarisation signal measured. Each was diluted a further 2S-fold prior to assay and 50 !AL transferred to the reaction tube followed by SOO IJ.L of fluorescein-labelled 4-aminosalicylic acid (30 nmol/L) and HKlO IJ.L of an appropriately diluted antiserum. The whole antiserum from the fourth bleed of one particular sheep was used throughout at a final dilution of 1:400. The standards were run in duplicate and a 'zero' was included, with 50 IJ.L of buffer in place of standard. After 30 min incubation at ambient temperature. fluorescence polarisation was measured.
CROSS-REACTIVITY STUDIES
Analytes were assayed for cross-reactivity by dissolving them in the appropriate solvent at a concentration of SO<Kl mglL and assaying SO IJ.L of a 2S-fold dilution (equivalent to five times the concentration of the top salicylate standard). Analogues were said not to cross-react if they failed to cause a fall in the polarisation signal greater than three standard deviations MEASUREMENT OF FI.UORESCENCE
POI.ARISATION
This was performed using a Model 4(Kl() polarisation fluorometer (SLM Instruments. Urbana, IL 61XIII, USA) which has aT-format. The cuvette containing the 1·55 mL of reaction mixture was excited with vertically polarised light of the appropriate wavelength (492 nm) and the intensity of the vertically (Vv) and horizontally (Vh) polarised components of the emitted light measured at 517 nm. The polarisation value is defined as:
(Vv+Vh)
The maximum theoretical range for P is from () to O·S and in order to make the values easier to use, results were multiplied by IIKlO and referred to as mP, the maximum value of which is thus 5(Kl mP.
Results
FLUORESCEIN-I.ABELI.ED SAI.ICYLATE
AND ASSESSMENT OF ANTISERUM
Fluorescein-labelled 4-aminosalicylic acid in diluent huffer at a concentration of II) nmollL gave a small signal of 30 mP. The presence of high concentrations of normal sheep serum caused a marked increase in signal due to nonspecific binding of the label by albumin and/or other serum proteins. However. this fell to near base-line values at dilutions of I:240 or greater. In contrast. all six immunised sheep produced specific antibodies which caused an increase in the signal to more than 200 mP and a typical antibody dilution curve is shown in Fig. 2 . Figure 2 also shows that the antiserum contains populations of antibodies that preferentially hind the label as compared with unlabelled salicylic acid. If both were rccog-Antibodies to salicylate 377 nised equally then the eurve obtained with 100 nmol/L of lahelled analyte would be superimposahle with that given with 10 nmol/L of lahel and 90 nmollL of unlabelled drug. As an approximation, it would require at least 10 times more salicylic acid than labelled 4aminosalicylic acid for the former to compete equally for the limited numher of antibodybinding sites.
STANDARD CURVES AND
CROSS-REACTIVITI ES
The antiserum was used at a final dilution of t :400 based on the ohservation that. in the absence of unlabelled drug, this produced a 0). which was taken as cross-reacting IIKI'y..; benzoic acid (0). us an example of an analyte that did not cross-react; o-aminobcnzoic acid (e). as an example of an analyte that had significant cross-reactivity less than IOIl'Yo; and p-aminosalicylic 'Kid (.). as an example of a compound that had cross-reactivity greater than IIKI%. The antiserum was used in the assay at a final dilution of 1/4IHI; IIKKI!iL being incubated with label (5IKI !iL; final concentration 10 nmol/L) and unalytc (511 III of a 25-fold dilution). signal of about ZOO mP. At this dilution all available binding sites are occupied by the label, some of which must remain unbound. The curves obtained for salicylic acid and for examples from three groups of the compounds tested are shown in Fig. 3 , namely those obtained for: (i) benzoic acid as an example of an analyte that showed no cross-reactivity; (ii) a-aminobenzoic acid, which cross-reacted significantly, but to a lesser extent than salicylic acid; and (iii) p-aminosalicylic acid, which cross-reacted to a greater extent than salicylic acid. At 5000 mg/L the concentration of the analogues being tested (which lie in the approximate range 75-HK) nmol per tube) are several thousand times higher than that of the fluorophore-Iabelled analyte (approximately 15 pmol).
Immunoreactivity of analytes with variations of the phenolic group
The importance of the phenolic hydroxyl of salicylic acid to recognition and binding by the antibodies was investigated using analogues that lacked this group or contained alternative functions of various chemical nature (Table I) .
The specificity of the antibodies is remarkable in that the absence 01' the ortho phenolic hydroxyl [compound (a)l or its replacement with one at the meta position [compound (h)l \cads to complete loss of immunoreactivity.
Replacement of the phenolic hydroxyl by a methoxy group [compound (cj], chlorine [compound (d)1 or a methyl group [compound (ej]
has the same effect. Thus, the antibodies have high specificity for the structure of salicylic acid, requiring both functional groups to be present in the correct spatial arrangement relative to each other. It is likely that the ability of the phenolic group to form an anion is an important factor since none of the three functions with which it was replaced above form anions under these conditions.
In compounds (f) and (g) the phenolic group OS" 0-. 1 TA8!.E I. Cross-reactivities Ior analytes with variations of the phenolic group are shown together with their molecular structures. All cross-reactivities were calculated relative to that of salicylic acid. Zero values indicate that there was no decrease in the polarisation signal observed at an analyte concentration of 5 giL. Letters in parentheses refer to those in the text the importance of electrostatic interactions (facilitated by the ionisation of functional groups) is reflected in the low immunoreactivity of compounds (f) and (g) relative to salicylic acid. since neither the amino group or the sulphydryl group would be able to form anions under these conditions.
Immunoreactivity of analytes with variations of the carboxylic acid group
Having established the importance of both the chemical nature and spatial arrangement of the phenolic group. the same features were examined for the carboxylic acid group (Table 2) . Its absence (compound (h)J or its replacement with an amide group (compound (i»). an alcoholic group (compound (Hl or a cyanide group (compound (k)] results in total loss of immunoreactivity. Again. this may be related to the fact that the carboxylic acid group in salicylic acid will tend to exist as the anion and is thus prominent in electrostatic interactions at the antibody-binding site. Thus. none of the other groups are able to ionise in this manner.
Compound (I) is of interest since its immunoreactivity. although small. supports earlier conclusions concerning the importance of charge to recognition of a hapten analogue hy antibodies raised to a charged hapten. Although the nell charge of the nitro group is zero. there is a separation of charge in this group which seems sufficient to allow a degree of immunoreactivity. Among the most interest- ing compounds that exhibit no immunoreactivity is compound (m) where both the carboxylic acid and phenolic hydroxy groups arc present in the same relative positions as in salicylic acid, but there is a methylene group between the carboxylic acid and the phenyl ring. There are two probable reasons for this finding: first that the antibody-binding sites accommodate the Antibodies to salicylate 381 hapten with such a close 'fit' that the extra group prevent antibody binding; and, second, that the interaction of the pi electrons of the carboxylate anion with the phenyl ring electrons Iwhich is prevented from occurring in compound (m) by the additional methylene group] gives rise to a very specific electronic 'shape' essential for antibody recognition and binding. 
Immunoreactivity of analytes with a para-positioned group
Although all cross-reactivities presented here are calculated relative to that of salicylic acid, the antibodies were raised to a para-substituted derivative of salicylic acid. The influence of this para-positioned group on antibody binding was investigated using analytes which had various groups substituted para to carboxylic acid, some of which also contained an orthosubstituted hydroxyl group ( Table 3) .
The slight immunoreactivity seen with compounds (n), (0), (p) and (q) is at variance with the conclusions drawn above concerning the importance of the presence and spatial arrangement of the functional groups. It would seem that the presence of a para-positioned functional group gives the compounds sufficient similarity to the immunogen for there to be some recognition by the antibodies. The nature of the pam-positioned group does not appear important, with approximately equal crossreactivity being seen for compound (p), where the para-positioned group is dissimilar to that present in the immunogen, and compound (g) where the para-positioned N-methyl group is similar to the 4-uminosalicylic acid-glutaraldehyde link in the immunogen.
When both the phenolic and carboxylic groups are present in the same relative positions as in salicylic acid and a para-positioned group is also present. us in compounds (r), (s) and (t). the immunoreactivity is at least equal to, and in the case of 4-uminosalicylic acid greater than, that of salicylic acid. This is explained by the presence of an amine link in the para-position of the immunogen and since introduction of a chlorine or a phenolic group docs not alter the immunoreactivity. it seems that these groups neither interfere with nor assist antibody recognition and binding relative to salicylic acid, However, it is notable that in compound (u) where a second phenolic group is placed at ring position five ruther than four (the para-position), immunoreactivity is reduced considerably, demonstrating the specificity of the antibodies to the precise spatial relationships of all the functional groups found in the hapten.
Immunoreactivity 0" analytes with variations in the phenyl ring
Compounds (v)-(y) ( Table 4) introduction of a ring nitrogen into benzoic acid leads to immunoreactivity where previously, in benzoic acid (compound (<1)1 there had been none. The free lone pair of electrons that the nitrogen possesses may allow some recognition by the antibodies that are 'expecting' a phenolic hydroxyl at this position. The N-oxide in compound (w) gives greater cross-reactivity. When both the acid and phenol groups are present in their 'correct' positions the presence of the ring nitrogen, <IS in compounds (x) and (y), has a disruptive effect on immunoreactivity relative to salicylic acid, more evidence of the remarkable specificity of these antibodies to the precise structure and electronic configuration of the hapten against which they were raised.
Clearly, the phenyl ring is almost as prominent in antibody binding and recognition as the other two functional groups.
Discussion
Landsteiner's papers on this subject span several decades, indicating the restrictions placed upon him and his colleagues by the techniques then available. Landsteiner also had problems in obtaining pure chemicals for preparing immunogens in his inhibition studies. Thus, there is value in repeating his fundamental investigations using modern developments in instrumentation and immunoassay design and the pure products now available. These techniques also allow a greater speed and precision.
It proved relatively straightforward to raise antibodies to 4-aminosalicylic acid coupled to KLH via glutaraldehyde. No success W<lS achieved using S-formylsalicylic acid directly linked to the carrier protein (unpublished results), indicating the need for a 'bridge' between the two. The standard curves obtained with salicylic acid and 4-aminosalicylic acid using antisera raised against the hapten-carrier conjugate indicates that a hapten-specific response has occurred. However, the size of the antibody-binding site, which has been found to be in the order of four amino acids," more than accommodates the salicylic acid moiety and it would be expected that populations of antibodies recognise and bind the salicylic acid, the glutaraldehyde bridge and, possibly, part of the KLH carrier protein.
The compounds studied fall into two categories; those that suggest the extent to which the antibodies accommodate the hapten plus bridge and those that provide information concerning the specificity of the antibodies raised against the 4-<lminosalicylic acid-KLH conjugate.
Since the immunogen has an amino group in the para-position, it is not surprising that 4aminobenzoic acid was twice as effective <IS salicylic acid in competing with the label for <Inti body-binding sites. This supports the view that the antibodies recognise and bind the whole hapten plus the bridge. On this basis, the much greater immunoreactivity of the fluorescein-labelled 4-aminosalicylic acid as compared with salicylic acid would be predicted, since the label also contains a paraamino grouping.
Fortunately, the assay is still of clinical value since serum levels of salicylic acid in patients lie in the mmoVL range. which is greatly in excess of the amount of label used. Thus, the analyte can compete, albeit unequally, with the label for the antibody-binding site.
The results obtained support the current concept that antibody binding involves electrostatic and hydrophobic interactions as well as hydrogen bonding. For salicylic acid where both electrostatic (carboxylic acid and phenolic hydroxyl) and hydrophobic groups (the phenyl ring) are present, these forces seem to be of roughly equal importance to antibody binding since alterations of either the phenyl ring or the substituted groups have a marked effect on immuno-reactivity.
Obviously, this information concerns only a particular hapten linked to a particular carrier protein by a particular bridge. Ideally, similar studies should be carried out on a number of different haptens of various chemical character in order to obtain a more complete picture of the factors influencing immunoreactivity. The information obtained would be of considerable value in understanding the fundamental nature of antibody specificity, and in the design of immunogens and labelled analytes for all hapten immunoassays.
An assay for serum salicylic acid levels is being developed subsequent to this work and the cross-reactivities of the major metabolites of the salicylates have been investigated. Although not described here. on the basis of the information obtained above concerning the close fit of the antibodies for the steric and electronic characteristics of the hapten, it is not surprising that these metabolites, which contain sugar or glycine residues, have no significant cross-reactivity with the antiserum.
